Azithromycin treatment modifies airway and blood gene expression networks in neutrophilic COPD
Long-term, low-dose azithromycin reduces exacerbation frequency in chronic obstructive pulmonary disease (COPD), yet the mechanism remains unclear. This study characterised genome-wide gene expression changes in patients with neutrophilic COPD following long-term, low-dose azithromycin treatment. Pa...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2018-11-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/4/4/00031-2018.full |